Nicola Polverelli

Nicola Polverelli

UNVERIFIED PROFILE

Are you Nicola Polverelli?   Register this Author

Register author
Nicola Polverelli

Nicola Polverelli

Publications by authors named "Nicola Polverelli"

Are you Nicola Polverelli?   Register this Author

46Publications

1111Reads

50Profile Views

Clinical Care of Hematological Patients in a Bone Marrow Transplant Unit: Do Human Resources Influence Infection Incidence?

Infect Control Hosp Epidemiol 2017 09 31;38(9):1131-1132. Epub 2017 Jul 31.

1Clinical and Experimental Sciences Department,University of Brescia,Bone Marrow Transplant Unit,ASST-Spedali Civili,Brescia,Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/ice.2017.157DOI Listing
September 2017

Mutations in and genes are associated with specific alterations of the immune system in myelofibrosis.

Oncoimmunology 2017 5;6(10):e1345402. Epub 2017 Jul 5.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1345402DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665081PMC
July 2017

The relevance of a low JAK2V617F allele burden in clinical practice: a monocentric study.

Oncotarget 2017 Jun;8(23):37239-37249

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology 'L. and A. Seràgnoli', University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16744DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514906PMC
June 2017

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

Eur J Haematol 2017 Apr 20;98(4):371-377. Epub 2017 Jan 20.

Department of Hematology, Azienda Sanitaria Universitaria Integrata S. Maria della Misericordia, Udine, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12839DOI Listing
April 2017

Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients.

Am J Hematol 2017 Jan 12;92(1):37-41. Epub 2016 Nov 12.

Department of Experimental, Diagnostic and Specialty Medicine (DIMES), Institute of Hematology and Clinical Oncology "L. and A. Seràgnoli", Sant'Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24572DOI Listing
January 2017

Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.

Transplantation 2016 Dec;100(12):e147-e155

1 Hematology, Bone Marrow Transplantation Unit, Department of Clinical and Experimental Sciences, University of Brescia, Italy. 2 Immunohematology and Transfusion Medicine Unit, AO Spedali Cvili, Brescia, Italy. 3 SODc Terapia Cellulare e Medicina Trasfusionale, AOU Careggi, Firenze, Italy. 4 Divisione di Ematologia, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 5 SC Ematologia, Istituto Nazionale Tumori, Milano, Italy. 6 Clinica Ematologica e Unità di terapie Cellulari, DISM, Università di Udine, Italy. 7 Centro di Ricerca Emato-oncologica AIL (CREA) Brescia, AO Spedali Civili di Brescia, Italy. 8 Unità di Cellule Staminali, Istituto Europeo di Oncologia, Milano, Italy. 9 Medicina Trasfusionale, Azienda Ospedaliero-Universitaria di Udine, Italy. 10 UO di Emotrasfusione, Fondazione Policlinico Universitario Agostino Gemelli, Università Cattolica del Sacro Cuore, Roma, Italy. 11 Bone Marrow Transplant Unit SODc Ematologia, AOU Careggi, Firenze, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/TP.0000000000001466DOI Listing
December 2016

Circulating Calreticulin Is Increased in Myelofibrosis: Correlation with Interleukin-6 Plasma Levels, Bone Marrow Fibrosis, and Splenomegaly.

Mediators Inflamm 2016;2016:5860657. Epub 2016 Sep 8.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. and A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/5860657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031875PMC
September 2016

Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegaly.

Br J Haematol 2016 07 28;174(1):160-2. Epub 2015 Oct 28.

Department of Haematology and Oncology, Città della Salute e della Scienza Hospital, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13758DOI Listing
July 2016

Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years.

Am J Hematol 2016 Jun;91(4):E267-72

Institute of Hematology "L. E A. Seràgnoli," Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajh.24310
Publisher Site
http://dx.doi.org/10.1002/ajh.24310DOI Listing
June 2016

Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia.

Immunol Lett 2015 Jul 2;166(1):63-4. Epub 2015 May 2.

Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imlet.2015.04.006DOI Listing
July 2015

Ruxolitinib-associated tuberculosis: a case of successful ruxolitinib rechallenge.

Ann Hematol 2015 Mar 30;94(3):519-20. Epub 2014 Aug 30.

Institute of Hematology "L. and A. Seràgnoli," St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2183-0DOI Listing
March 2015

Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis.

Ann Hematol 2015 Feb 4;94(2):339-41. Epub 2014 Jul 4.

Institute of Hematology "L. and A. Seràgnoli", St Orsola-Malpighi Hospital, Department of Specialistic, Diagnostic and Experimental Medicine, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-014-2156-3DOI Listing
February 2015

The choice of second-line therapy in steroid-resistant immune thrombocytopenia: role of platelet kinetics in a single-centre long-term study.

Am J Hematol 2014 Nov 27;89(11):1047-50. Epub 2014 Aug 27.

Institute of Hematology "L. and A. Serágnoli", Department of Experimental, Diagnostic and Specialty Medicine, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23823DOI Listing
November 2014

A case report of acute myeloid leukemia and neurofibromatosis 1.

Hematol Rep 2013 Jun 3;5(2):28-9. Epub 2013 Jul 3.

Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2013.e8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719102PMC
June 2013

Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia.

Ann Hematol 2013 Jan 31;92(1):67-78. Epub 2012 Aug 31.

Institute of Hematology, Department of Hematology and Oncological Sciences L. e A. Seràgnoli, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-012-1556-5DOI Listing
January 2013

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency.

Hematol Rep 2012 May 26;4(2):e10. Epub 2012 Jun 26.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna;

View Article

Download full-text PDF

Source
http://www.pagepress.org/journals/index.php/hr/article/view/
Publisher Site
http://dx.doi.org/10.4081/hr.2012.e10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401131PMC
May 2012

Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.

Ann Hematol 2011 Aug 2;90(8):933-8. Epub 2011 Feb 2.

Department of Hematology and Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00277-010-1154
Web Search
http://link.springer.com/10.1007/s00277-010-1154-3
Publisher Site
http://dx.doi.org/10.1007/s00277-010-1154-3DOI Listing
August 2011

The CD47 pathway is deregulated in human immune thrombocytopenia.

Exp Hematol 2011 Apr 4;39(4):486-94. Epub 2011 Jan 4.

Department of Hematology and Oncological Sciences L. & A. Seràgnoli, Institute of Hematology, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2010.12.011DOI Listing
April 2011

Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.

Am J Hematol 2009 Apr;84(4):215-20

Department of Hematology and Medical Oncology L. e A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21360DOI Listing
April 2009

Association of essential thrombocythemia and non-Hodgkin lymphoma: a single-centre experience.

Leuk Lymphoma 2009 Mar;50(3):481-4

Department of Hematology/Oncology, L and A Seragnoli, St Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802713521DOI Listing
March 2009

JAK2 V617F mutation in essential thrombocythemia: correlation with clinical characteristics, response to therapy and long-term outcome in a cohort of 275 patients.

Leuk Lymphoma 2009 Feb;50(2):247-53

Department of Hematology and Clinical Oncology L. and A. Seràgnoli, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802688152DOI Listing
February 2009